Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 7/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.55 |
| ▸ | CA2 | P00918 | 3/20 | 0.55 |
| ▸ | CA9 | Q16790 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | LGALS1 | P09382 | 2/20 | 0.47 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.47 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.47 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1647658 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL18722237 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL19538490 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL14707760 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL3228008 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL12038703 | 1.00 | PYGB (0.58) | PYGBGAACA12CA1CA2 | |
| SCHEMBL9650344 | 0.98 | PYGB (0.55) | PYGBGAACA12CA1CA2 | |
| SCHEMBL8059606 | 0.98 | PYGB (0.55) | PYGBGAACA12CA1CA2 | |
| SCHEMBL23430833 | 0.82 | LGALS8 (0.53) | PYGBCA12CA1CA2CA9 | |
| SCHEMBL21894588 | 0.82 | LGALS8 (0.53) | PYGBCA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2306195-A2 | Biological applications of semiconductor nanocrystals | Massachusetts Institute of Technology (US) | 2011-04-06 | — | — | EP | disclosed |
| US-7521430-B2 | N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-20070060545-A1 | Novel compounds | TANABE SEIYAKU CO., LTD. (JP) | 2007-03-15 | — | — | US | disclosed |
| EP-1116036-B1 | WATER-SOLUBLE FLUORESCENT SEMICONDUCTOR NANOCRYSTALS | MASSACHUSETTS INST TECHNOLOGY (US) | 2004-08-11 | — | — | EP | disclosed |
| US-6602671-B1 | Semiconductor nanocrystals for inventory control | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2003-08-05 | — | — | US | disclosed |
| EP-0990903-B1 | Biological applications of semiconductor nanocrystals | MASSACHUSETTS INST TECHNOLOGY (US) | 2003-03-12 | — | — | EP | disclosed |
| EP-1271154-A2 | Biological applications of semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2000017103-A9 | INVENTORY CONTROL | MASSACHUSETTS INST TECHNOLOGY (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-0775117-B1 | FLUORINATED 2-NITROIMIDAZOLE ANALOGS FOR DETECTING HYPOXIC TUMOR CELLS | STANFORD RES INST INT (US) | 2001-11-21 | — | — | EP | disclosed |
| US-6319426-B1 | NANOCRYSTAL CORE HAVING A SELECTED BAND GAP ENERGY; SHELL OF A SEMICONDUCTOR MATERIAL HAVING A BAND GAP ENERGY GREATER THAN THAT OF THE CORE; OUTER LAYER MOLECULE HAVING AT LEAST TWO LINKING GROUPS AND AT LEAST ONE HYDROPHILIC GROUP | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2001-11-20 | — | — | US | disclosed |
| WO-2000017655-A9 | WATER-SOLUBLE FLUORESCENT SEMICONDUCTOR NANOCRYSTALS | MASSACHUSETTS INST TECHNOLOGY (US) | 2001-10-04 | — | — | WO | disclosed |
| EP-1116036-A1 | WATER-SOLUBLE FLUORESCENT SEMICONDUCTOR NANOCRYSTALS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-07-18 | — | — | EP | disclosed |
| EP-1113986-A2 | INVENTORY CONTROL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2001-07-11 | — | — | EP | disclosed |
| EP-0990903-A1 | Biological applications of semiconductor nanocrystals | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-04-05 | — | — | EP | disclosed |
| WO-2000017655-A1 | WATER-SOLUBLE FLUORESCENT SEMICONDUCTOR NANOCRYSTALS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-2000017103-A2 | INVENTORY CONTROL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2000-03-30 | — | — | WO | disclosed |
| US-5721265-A | FOR MAGNETIC RESONANCE IMAGING | SRI INTERNATIONAL (US) | 1998-02-24 | — | — | US | disclosed |
| EP-0775117-A1 | FLUORINATED 2-NITROIMIDAZOLE ANALOGS FOR DETECTING HYPOXIC TUMOR CELLS | SRI INTERNATIONAL (US) | 1997-05-28 | — | — | EP | disclosed |
| WO-1996004249-A9 | FLUORINATED 2-NITROIMIDAZOLE ANALOGS FOR DETECTING HYPOXIC TUMOR CELLS | — | 1996-03-21 | — | — | WO | disclosed |
| WO-1996004249-A1 | FLUORINATED 2-NITROIMIDAZOLE ANALOGS FOR DETECTING HYPOXIC TUMOR CELLS | SRI INTERNATIONAL (US) | 1996-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060545-A1 | Novel compounds | CYP1B1, CYP2B6, CYP4B1 | PYGB 4771/4885GAA 3192/4885CA12 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.